title: [What helps for persistent symptoms of asthma during inhalative steroid therapy?].
authors: C
authors: C
authors: Kroegel
mesh_terms: D000085:Acetates / Q000008:administration & dosage; D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D058666:Adrenergic beta-2 Receptor Agonists / Q000008:administration & dosage*; D000328:Adult; D000420:Albuterol / Q000008:administration & dosage / Q000031:analogs & derivatives; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage*; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000008:administration & dosage; D002648:Child; D003521:Cyclopropanes; D004359:Drug Therapy, Combination; D004983:Ethanolamines / Q000008:administration & dosage; D000068759:Formoterol Fumarate; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage / Q000031:analogs & derivatives; D020024:Leukotriene Antagonists / Q000008:administration & dosage*; D011788:Quality of Life; D011804:Quinolines / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D012129:Respiratory Function Tests; D000068299:Salmeterol Xinafoate; D013440:Sulfides; D017211:Treatment Failure
chemical_list: D000085:Acetates; D000305:Adrenal Cortex Hormones; D058666:Adrenergic beta-2 Receptor Agonists; D018927:Anti-Asthmatic Agents; D001993:Bronchodilator Agents; D003521:Cyclopropanes; D004983:Ethanolamines; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; D000068299:Salmeterol Xinafoate; C093875:montelukast; D000420:Albuterol; C063449:zileuton; D000068759:Formoterol Fumarate; D006918:Hydroxyurea